2026 NPPES data Speech-Language Pathologist NPI 1922402189 PA-S
Verify on CMS →

MINA BARATIFAR, PA-S

Speech-Language Pathologist in DALLAS, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
665
Medicare Part D claims · 176 beneficiaries · Speech-Language Pathologist avg: 323
Generic prescribing
94%
generic claims · 6% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$2.0K
92 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MINA BARATIFAR, PA-S filed 665 Medicare Part D claims in 2023 as a Speech-Language Pathologist in DALLAS, Texas, prescribing 94% generic.

665
Part D claims, 2023
94%
generic prescribing
$2.0K
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MINA BARATIFAR, PA-S's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

665 Top 31% higher than 69% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). This entry sits in this band. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about MINA BARATIFAR, PA-S?

Quality data not reported

NPI registry status

Active

Issued 10/17/2014

NPI 1922402189

Primary specialty

Speech-Language Pathologist

High-volume

188,278 US NPIs in this specialty

Medicare Part D claims

665 106% vs specialty avg

2023 prescription claims

Specialty avg: 323

Specialty distribution in Texas

How Speech-Language Pathologist compares to other specialties among Texas providers

Texas providers

Speech-Language Pathologist share within Texas

1. Speech-Language Pathologist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Speech-Language Pathologist share within Texas

Specialty board-certification context

Estimated specialty board-certified rate — Speech-Language Pathologist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Speech-Language Pathologist ABMS/AOA estimate

Est. board-certified rate (Speech-Language Pathologist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Speech-Language Pathologist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MINA BARATIFAR, PA-S appears in the CMS NPPES registry as a Speech-Language Pathologist provider holding PA-S credentials at 8390 LYNDON B JOHNSON FWY STE 1000, DALLAS, TX, 75243, with a listed phone of (214) 750-9977. NPI 1922402189 was issued on 10/17/2014. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BARATIFAR most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 665 prescription claims written by this provider, covering 176 Medicare beneficiaries and totaling roughly $99K in drug spend, split 6% brand-name and 94% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Speech-Language Pathologist is a high-volume specialty nationwide, with 188,278 enrolled providers across 55 states and an average of 323 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

8390 LYNDON B JOHNSON FWY STE 1000
DALLAS, TX 75243

Provider Details

NPI 1922402189
Specialty Speech-Language Pathologist
Credentials PA-S
Gender Female
NPI Issued 10/17/2014

Hospital and facility affiliations

Facilities where MINA BARATIFAR, PA-S bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

NEUROLOGY CONSULTANTS OF DALLAS, P.A.
DALLAS, TX
TEXAS HEALTH PHYSICIANS GROUP
DALLAS, TX

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MINA BARATIFAR, PA-S. Source: openpaymentsdata.cms.gov.

Total received

$2.0K

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to MINA BARATIFAR, PA-S. To verify MINA BARATIFAR, PA-S's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

MINA BARATIFAR, PA-S — brand share 6.0%
Specialty average (est.)

6% brand-name claims vs 94% generic, on 665 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

665
Total Claims
$99K
Total Drug Cost
176
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,228
Total Day Supply
36,029
Brand vs Generic
6% brand / 94% generic
Brand Drug Cost
$77K
Generic Drug Cost
$22K

Patient Demographics

Average Patient Age
74.7 years
Avg HCC Risk Score
1.64
Gender Split
57% female / 43% male
Age Distribution
<65: 20, 65-74: 64, 75-84: 69, 85+: 23

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MINA BARATIFAR, PA-S prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Gabapentin
111
Levetiracetam
48
Prednisone
34
Carbidopa-Levodopa
Carbidopa/Levodopa
30
Pregabalin
30
Donepezil Hcl
27
Zonisamide
27
Amitriptyline Hcl
26
Memantine Hcl
23
Topiramate
23

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Speech-Language Pathologist Overview

How MINA BARATIFAR, PA-S fits within the Speech-Language Pathologist landscape nationally.

188,278
Speech-Language Pathologist Providers in US
55
States with Speech-Language Pathologist
323
Avg Claims per Provider

MINA BARATIFAR, PA-S's 665 claims are above the specialty average of 323.

Nearby Speech-Language Pathologist Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as BARATIFAR.

Compare Speech-Language Pathologist nationally: see state-by-state distribution →

Frequently Asked Questions

What is MINA BARATIFAR, PA-S's specialty?
MINA BARATIFAR, PA-S specializes in Speech-Language Pathologist and practices in DALLAS, Texas. Credentials: PA-S.
How much does MINA BARATIFAR, PA-S prescribe under Medicare Part D?
In 2023, MINA BARATIFAR, PA-S wrote 665 Medicare Part D claims totaling $99K in drug costs for 176 beneficiaries.
Where is MINA BARATIFAR, PA-S located?
MINA BARATIFAR, PA-S is located at 8390 LYNDON B JOHNSON FWY STE 1000, DALLAS, TX, 75243. Phone: (214) 750-9977.
What is MINA BARATIFAR, PA-S's NPI number?
MINA BARATIFAR, PA-S's National Provider Identifier (NPI) is 1922402189, issued on 10/17/2014.
Does MINA BARATIFAR, PA-S prescribe more brand-name or generic drugs?
MINA BARATIFAR, PA-S's prescribing is 6% brand-name and 94% generic drugs by claim count, with $77K in brand drug costs.
How many Speech-Language Pathologist providers are there in the US?
There are 188,278 Speech-Language Pathologist providers across 55 states in the US. The average Speech-Language Pathologist provider writes 323 Medicare Part D claims per year.
What drugs does MINA BARATIFAR, PA-S prescribe most often?
Based on 2023 Medicare Part D data, MINA BARATIFAR, PA-S's most frequently prescribed drugs include Gabapentin, Levetiracetam, Prednisone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MINA BARATIFAR, PA-S accept Medicare?
MINA BARATIFAR, PA-S appears in CMS Medicare data with 665 Part D claims and 176 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MINA BARATIFAR, PA-S's credentials?
MINA BARATIFAR, PA-S's NPI is 1922402189 with credentials PA-S. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology